| Revenue | NOK 0 | — |
| EBITDA | NOK -27K | -6% |
| Net profit | NOK -5K | +92% |
| Total assets | NOK 173K | +30% |
| Equity | NOK 168K | +29% |
| Employees | 0 | — |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −12 | −31 | −36 | −20 | −20 | −27 | −25 | −27 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −12 | −31 | −36 | −20 | −20 | −27 | −25 | −27 |
| Net financials | −35 | −168 | −191 | −11 | −11 | −7 518 | −39 | 9 |
| Profit before tax | −47 | −199 | −227 | −31 | −32 | −7 545 | −64 | −17 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −12 |
| Net profit | −47 | −199 | −227 | −31 | −32 | −7 545 | −64 | −5 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 3 179 | 3 246 | 7 542 | 7 540 | 7 539 | 585 | 133 | 173 |
| Equity | −17 | −111 | 7 252 | 7 221 | 7 189 | 194 | 130 | 168 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 196 | 3 357 | 290 | 319 | 349 | 391 | 3 | 5 |
| Total debt | 3 196 | 3 357 | 290 | 319 | 349 | 391 | 3 | 5 |
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Hemaca As | Company | 100.0% | 100.0% | 2023 |
| Person | Role here | Other companies |
|---|---|---|
| Sverre Skogen | Chairman | 0 companies |